美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

HORIZON KINETICS MEDICAL ETF

35.24

-0.2499-0.70%

盤後：35.250.0137+0.04%16:10 EDT

成交量：732

成交額：2.58萬

市值：1,655.92萬

市盈率：- -

高：35.25

開：35.25

低：35.24

收：35.49

52周最高：37.90

52周最低：28.87

股本：46.99萬

流通股本：46.99萬

量比：1.05

換手率：0.16%

股息：0.41

股息率：1.16%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

突發異動！300434，3分鐘直線20%漲停！創新藥，集體爆發！

國信證券：醫藥中報景氣度提升繼續推薦創新藥及產業鏈

創新藥概念走強金斯瑞生物科技（01548）升逾15% 機構指醫藥行業基本面持續改善

創新藥、CRO概念漲勢擴大近岸蛋白等多股漲停

泰順，緣何颳起「科技風」

創新藥板塊短線走高，金石亞藥觸及20cm漲停

三重動力支撐創新藥企「強者更強」

諾華製藥(NVS.US)：VHB937未達到其主要終點和次要終點。根據2期ASTRALS研究結果，已停止VHB937用於

諾華宣佈終止ALS藥物VHB937的研發。

強生：鋭珂捷®埃萬妥單抗注射液在中國上市

Circle Pharma融資新動態：Column Group領投，禮來戰略入股

安圖生物高敏HIV-1核酸檢測試劑盒獲醫療器械註冊證

新產業：公司全自動核酸檢測分析系統獲得醫療器械註冊證

戴維醫療：醫療器械生產許可證新增兩類Ⅲ類生產範圍

內蒙古烏蘭察布市市場監管局紮實推進醫療器械抽檢工作

中国质量新闻网

新加坡醫療服務提供商LYC Healthcare IPO定價4美元/股籌資規模上調67%至2500萬美元

新加坡醫療服務提供商LYC Healthcare IPO定價4美元/股籌資規模上調67%至2500萬美元

新加坡醫療服務提供商LYC Healthcare IPO定價4美元/股籌資規模上調67%至2500萬美元

創新藥概念股表現活躍

香港：建設國際藥械權威監管機構建立自主藥械審評能力

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/MEDX/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":35.2363,"timestamp":1789761600000,"preClose":35.4862,"halted":0,"volume":732,"hourTrading":{"tag":"盘后","latestPrice":35.25,"preClose":35.2363,"latestTime":"16:10 EDT","volume":6,"amount":211.4178,"timestamp":1789762204085,"change":0.0137,"changeRate":0.000389,"amplitude":0},"delay":0,"changeRate":-0.007042174140933566,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"休市中","change":-0.2499,"latestTime":"09-18 16:00:00 EDT","open":35.25,"high":35.25,"low":35.2363,"amount":25837,"amplitude":0.000386,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":35.4862,"sharesOutstanding":569946,"nav":35.46,"aum":16664285.16,"dividendRate":0.011607,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.25,"preClose":35.2363,"latestTime":"16:10 EDT","volume":6,"amount":211.4178,"timestamp":1789762204085,"change":0.0137,"changeRate":0.000389,"amplitude":0},"volumeRatio":1.0469104706622006},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0469104706622006,"shares":469946,"dividePrice":0.409,"high":35.25,"amplitude":0.000386,"preClose":35.4862,"low":35.2363,"week52Low":28.8652,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":35.2363,"eps":0,"divideRate":0.011607,"volume":732,"delay":0,"ttmEps":0,"open":35.25,"prevYearClose":33.2024,"prevWeekClose":34.9572,"prevMonthClose":36.417,"prevQuarterClose":36.7138,"fiveDayClose":34.9572,"twentyDayClose":37.0138,"sixtyDayClose":34.8443},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668047930","title":"突發異動！300434，3分鐘直線20%漲停！創新藥，集體爆發！","url":"https://stock-news.laohu8.com/highlight/detail?id=2668047930","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668047930?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 10:32","pubTimestamp":1789612320,"startTime":"0","endTime":"0","summary":"9月17日，A股主要指数集体低开。盘面上，视频媒体、房产租赁经纪、玻纤制造等板块涨幅居前，MLCC概念、贵金属、风电设备、油气开采等板块跌幅居前。创新药概念股走强创新药板块短线走高，金 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260917/c680001119.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260917/c680001119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK1161","BK1574","159992","MEDX","BK0028","BK0077","300434","IBBQ","BK0239","06978","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668958679","title":"國信證券：醫藥中報景氣度提升 繼續推薦創新藥及產業鏈","url":"https://stock-news.laohu8.com/highlight/detail?id=2668958679","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668958679?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 10:29","pubTimestamp":1789612194,"startTime":"0","endTime":"0","summary":"国信证券主要观点如下：医药行业中报景气度提升2026年上半年A股医药行业上市公司实现营业收入11942.1亿元，同比增长2.6%;归母净利润1049.6亿元，同比增长10.8%，利润增速明显快于收入端。整体来看，2026年上半年医药行业基本面持续改善，盈利修复趋势进一步确认，创新药及CXO等高景气方向表现突出。中国创新药在海外的临床开发取得进展，即将进入在全球的商业化阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497232.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","BK0188","BK1574","IBBQ","BK1161","BK0028","06978","002736","BK0183","159938","BK1515","159992","MEDX","LNGR","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668930750","title":"創新藥概念走強 金斯瑞生物科技（01548）升逾15% 機構指醫藥行業基本面持續改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2668930750","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668930750?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 10:29","pubTimestamp":1789612152,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股创新药概念走强，截止发稿，金斯瑞生物科技 涨15.29%，维亚生物涨6.32%，凯莱英涨6.08%，泰格医药涨4.86%，昭衍新药涨4.96%。消息面上，国信证券表示，2026年上半年医药行业收入保持稳健增长，利润端实现双位数增长，26Q2盈利增速进一步提升，创新药及产业链维持较高景气。整体来看，2026年上半年医药行业基本面持续改善，盈利修复趋势进一步确认，创新药及CXO等高景气方向表现突出。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/NmNiNTg2NTUyNjE5NjAwNw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NmNiNTg2NTUyNjE5NjAwNw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06127","BK1141","06978","BK1576","01548","BK1191","159992","06821","BK1574","MEDX","HK0000320223.HKD","IBBQ","03347","HK0000306701.USD","HK0000320264.USD","HK0000306685.HKD","LNGR","01873","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668470930","title":"創新藥、CRO概念漲勢擴大 近岸蛋白等多股漲停","url":"https://stock-news.laohu8.com/highlight/detail?id=2668470930","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668470930?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 10:26","pubTimestamp":1789611962,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","MEDX","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668930014","title":"泰順，緣何颳起「科技風」","url":"https://stock-news.laohu8.com/highlight/detail?id=2668930014","media":"泰顺发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668930014?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 10:05","pubTimestamp":1789610700,"startTime":"0","endTime":"0","summary":"最近，中国农技协发布科技小院认定名单，浙江康鸿生物科技有限公司的温栀子科技小院入选。这是继浙江泰顺中蜂科技小院之后，泰顺第二家获认定的国字号科技小院。“科技副总”便是很好的突破口。“科技特派员”是另一支常驻队伍。如今，康鸿生物科技已累计获得24项自主知识产权，栀子花相关产品附加值提升超300%。目前，泰顺黄栀子种植总产量已达每年6000多吨，延伸出年产值2.5亿元的生态美妆产业集群，带动2000多户种植户增收。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-17/doc-inisayan9385069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GDOC","BK4596","LU1496350502.SGD","ITB","LU0211331839.USD","BK4581","LNGR","BK4504","XBI","NAIL","DHI","LU0070302665.USD","BK4585","HBImain","BK4561","IEIH","IBBJ","LU2543165471.USD","BK4088","LU0208291251.USD","LU0320765489.SGD","MEDX","SYNB","AGNG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668937166","title":"創新藥板塊短線走高，金石亞藥觸及20cm漲停","url":"https://stock-news.laohu8.com/highlight/detail?id=2668937166","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668937166?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 09:35","pubTimestamp":1789608958,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","LNGR","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668987804","title":"三重動力支撐創新藥企「強者更強」","url":"https://stock-news.laohu8.com/highlight/detail?id=2668987804","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668987804?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 00:01","pubTimestamp":1789574460,"startTime":"0","endTime":"0","summary":"今年以来，创新药行业分化愈发明显。招商证券统计显示，91家A/H股创新药公司中，2026年上半年共有44家实现盈利，其中盈利额前五的公司占全部盈利公司利润总额的48%。中国创新药跨境BD（商务拓展）同样呈现集中趋势。据动脉智库数据，2026年上半年，中国创新药对外BD的潜在总额达1100亿美元，其中，交易金额体量排名前十的项目的总金额为739.14亿美元，占比在六成以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609173876437951.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609173876437951.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","06978","BK1574","LNGR","MEDX","159992","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667898420","title":"諾華製藥(NVS.US)：VHB937未達到其主要終點和次要終點。根據2期ASTRALS研究結果，已停止VHB937用於","url":"https://stock-news.laohu8.com/highlight/detail?id=2667898420","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667898420?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 23:39","pubTimestamp":1789573152,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["NVS","IE0009355771.USD","LU0320765489.SGD","BK4585","PPH","IE00B2B36J28.USD","LU0211331839.USD","BK4007","LU0070302665.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","BK4578","MEDX","BK4588","LU0208291251.USD","BK4532","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667898585","title":"諾華宣佈終止ALS藥物VHB937的研發。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667898585","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667898585?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:43","pubTimestamp":1789562627,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4588","IE0002141913.USD","LU0211331839.USD","IE00B2B36J28.USD","BK4007","BK4532","IE00BJJMRZ35.SGD","BK4578","IE00BJT1NW94.SGD","MEDX","NVS","LU0208291251.USD","IE00BFTCPJ56.SGD","LU0320765489.SGD","LU0070302665.USD","IE00B4R5TH58.HKD","PPH","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667885079","title":"強生：鋭珂捷®埃萬妥單抗注射液在中國上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2667885079","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667885079?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 19:49","pubTimestamp":1789559357,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1894683348.USD","BK4532","LU0943347566.SGD","IE00B1BXHZ80.USD","IXJ","LU1162221912.USD","SG9999001440.SGD","IE00B4R5TH58.HKD","LU2403377893.USD","BK4585","XLV","GDOC","BMED","SGXZ57979304.SGD","PJP","VHT","IHE","IE00B2B36J28.USD","LU0738911758.USD","LU1074936037.SGD","LU0162691827.USD","LU1196500208.SGD","LU0345770308.USD","IYH","LU1718418525.SGD","RXL","LU0426417589.USD","LU1061106388.HKD","LU1043141123.HKD","LU0426412945.USD","MEDX","LU2756315318.SGD","FHLC","JNJ","LU1280957306.USD","IPOS","IE00BFTCPJ56.SGD","LU0203345920.USD","FTXH","LU0122379950.USD","IE0034235303.USD","LU0345769128.USD","LU0098860793.USD","TRUH","LU0689472784.USD","IE000SO60NU8.SGD","BK4581","LU0795875086.SGD","LU2417539215.USD","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149338058","title":"Circle Pharma融資新動態：Column Group領投，禮來戰略入股","url":"https://stock-news.laohu8.com/highlight/detail?id=1149338058","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149338058?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 19:06","pubTimestamp":1789556772,"startTime":"0","endTime":"0","summary":"Circle Pharma近日宣布完成新一轮融资。此轮融资由Column Group领投，Nextech Invest与Ra Capital Management共同参与。值得注意的是，礼来公司也以战略投资者的身份加入其中。多方资本汇聚，既体现了投资界对Circle Pharma前景的认可，也凸显了制药巨头礼来在创新疗法领域的布局意图。从投资方结构来看，既有深耕生物医药的专业风投，也有全球领先的药企巨头，这种组合往往意味着更深层的战略协同可能性。Circle Pharma的研发管线或将成为这些资本力量交汇的焦点所在。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","LU0316494557.USD","LU2264538146.SGD","SG9999018857.SGD","LU0266013472.USD","SG9999015978.USD","LU2236285917.USD","ELIS","LU0114720955.EUR","LU0174119429.USD","LU0106261372.USD","LU0225283273.USD","LU2324357040.USD","LU2271345857.HKD","LU0256863902.USD","LU1280957306.USD","LU2896262040.SGD","LU1804176565.USD","SGXZ31699556.SGD","LU1979441026.SGD","LU2168564495.EUR","LU2213496289.HKD","SG9999018865.SGD","SG9999015952.SGD","LU2023250504.SGD","LU0820561909.HKD","LU2168564065.EUR","IE00B1BXHZ80.USD","LU0006306889.USD","SG9999013999.USD","TRUH","LU0354030438.USD","IE00BN29S564.USD","LU1868836591.USD","LU0198837287.USD","SG9999017495.SGD","IE0002141913.USD","LU2237443622.USD","LU2461242641.AUD","LU1061106388.HKD","LU2471134523.USD","IE0004445015.USD","BK4585","FHLC","LU0354030511.USD","LU0158827781.USD","LU1868836757.USD","LU0786609619.USD","LU1868837136.USD","LU2462157665.USD","LU0203202063.USD","IE00BJT1NW94.SGD","LU1035775433.USD","THNR","IE00BKPKM429.USD","IE00BJJMRY28.SGD","MEDX","IE00B2B36J28.USD","LU1868837300.USD","LU1629891620.HKD","LU0882574139.USD","LU1551013425.SGD","XLV","LU1023059063.AUD","LU0122379950.USD","LU2028103732.USD","LU2106854487.HKD","LU2111349929.HKD","SG9999001176.SGD","IE00BFSS7M15.SGD","IE0009355771.USD","OZEM","LLYX","IYH","LU2265009873.SGD","IE0001KFT4U8.USD","LU2357305700.SGD","IE00B1XK9C88.USD","SG9999015945.SGD","LU2237443978.SGD","LU2023250330.USD","IE00BJJMRZ35.SGD","RXL","ELIL","GDOC","IE0005OL40V9.USD","LU0345770308.USD","LU0079474960.USD","LU0466842654.USD","LU1057294990.SGD","LU2471134879.HKD","LU2756315664.SGD","LU0289739699.SGD","SG9999015986.USD","LU1814569148.SGD","CANC","LU0708995401.HKD","LU2462591350.SGD","HRTS","ILDR","LU2417539215.USD","LU2237443382.USD","LU2089284900.SGD","LU0823434740.USD","GB00BDT5M118.USD","LU1145028129.USD","LU0432979614.USD","LU2087625088.SGD","LU2552382132.HKD","LU2746668461.USD","LU2237443895.HKD","LU2471134952.CNY","LU0238689110.USD","LU1551013342.USD","WDNA","JDOC","LU2750360997.AUD","LU0820561818.USD","LU2471134796.USD","LU2756315318.SGD","PJP","LU1064131342.USD","SGXZ57979304.SGD","BK4533","LU0385154629.USD","IE00BKDWB100.SGD","LU1548497426.USD","LU1366192091.USD","SGXZ51526630.SGD","LU0061475181.USD","LU1868836914.USD","MEDI","LU2361045086.USD","IE00B775H168.HKD","IE00B7KXQ091.USD","BK4599","BK4534","LU0471298694.HKD","LLYZ","LU0417517546.SGD","LU2237438978.USD","LU1917777945.USD","SG9999014914.USD","LU0320765059.SGD","LU1232071149.USD","BK4581","IHE","LU0158827948.USD","LU1989771016.USD","LU0787776722.HKD","LU0109394709.USD","LU0320765992.SGD","LU2089984988.USD","LU2211815571.USD","MHIP","LU0133085943.USD","LLII","LU2491049909.HKD","LU0094547139.USD","IE0004445239.USD","LU0882574055.USD","LU1291159041.SGD","LU1974910355.USD","LU1983299246.USD","LU2491050071.SGD","LU0672654240.SGD","LU0323591593.USD","IE00B4R5TH58.HKD","LU0058720904.USD","LU0234572021.USD","LU1127390331.HKD","LU1720051017.SGD","LU2361044865.SGD","SG9999001176.USD","LU2491050154.USD","LU0889565916.HKD","PPH","LU1988902786.USD","LU0823434583.USD","LU2089283258.USD","IE00BJJMRX11.SGD","LU0943347566.SGD","LU1323610961.USD","LU2112291526.USD","LU2746668974.SGD","TMED","LU0345770993.USD","LU1691799644.USD","LU2063271972.USD","LU2108987350.USD","SG9999014880.SGD","LU0097036916.USD","LU1267930730.SGD","LU0353189680.USD","LU1623119135.USD","IE00BK4W5L77.USD","LU0820562030.AUD","BK4588","IE00BJLML261.HKD","LU0964807845.USD","LU2552382215.SGD","IE00BFTCPJ56.SGD","IE00B4JS1V06.HKD","LU0683600562.USD","SGXZ99366536.SGD","IXJ","CURE","LU2237443465.HKD","IE00BWXC8680.SGD","LU0210536198.USD","LU0256863811.USD","LU2361044949.HKD","IE00BFSS8Q28.SGD","LU2602419157.SGD","LU0689472784.USD","LU1093756168.USD","LU0109391861.USD","LU2168563687.JPY","LU2237443549.SGD","LU2168564222.USD","BK4516","LU2750360641.GBP","LU0203201768.USD","LU1093756325.SGD","LU2456880835.USD","LU0640476718.USD","LU1720051108.HKD","LU0823416689.USD","LU1712237335.SGD","AGNG","LU0471298777.SGD","SG9999014906.USD","BK4007","LU2360106947.USD","LU2168564149.EUR","SG9999014898.SGD","FTXH","LU2552382058.USD","SGXZ81514606.USD","LU1069344957.HKD","VHT","IE00BK4W5M84.HKD","LU0456855351.SGD","LU2023251221.USD","LU2468319806.SGD","LU0353189763.USD","LU0096364046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667601077","title":"安圖生物高敏HIV-1核酸檢測試劑盒獲醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2667601077","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667601077?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 17:42","pubTimestamp":1789551752,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LGHT","MDEV","GDOC","PTH","LNGR","MEDX","HART","RSPH","AGNG","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667606258","title":"新產業：公司全自動核酸檢測分析系統獲得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2667606258","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667606258?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 16:39","pubTimestamp":1789547975,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","GDOC","AGNG","IEIH","HART","RSPH","PTH","MDEV","MEDX","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667605655","title":"戴維醫療：醫療器械生產許可證新增兩類Ⅲ類生產範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=2667605655","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667605655?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 15:58","pubTimestamp":1789545498,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","LGHT","HART","GDOC","MEDX","IEIH","MDEV","RSPH","PTH","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667037996","title":"內蒙古烏蘭察布市市場監管局紮實推進醫療器械抽檢工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2667037996","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667037996?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 15:32","pubTimestamp":1789543920,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 2026年，内蒙古乌兰察布市市场监管局紧扣自治区抽检工作部署，扎实推进医疗器械抽检工作。紧扣自治区部署，对往年国抽不合格品种及区内严重伤害报告数较多品种优先安排、重点保障，确保高风险品种抽检任务足量完成。下一步，乌兰察布市市场监管局将提前摸排库存底数、强化人员培训、严格核查处置，切实守好群众用械安全底线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-16/doc-inirzfsy2892323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","RSPH","MDEV","BK1574","PTH","MEDX","09996","BK1583","159883","IEIH","BK1100","LGHT","AGNG","GDOC","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667158608","title":"新加坡醫療服務提供商LYC Healthcare IPO定價4美元/股 籌資規模上調67%至2500萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667158608","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667158608?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 14:57","pubTimestamp":1789541822,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，在新加坡运营医疗诊所和骨科手术中心的LYC Healthcare于周二提高了即将进行的首次公开募股的拟议发行规模。该公司目前计划发行630万股股票，拟议发行价为每股4美元，以筹集2500万美元。此前，公司已提交文件，计划发行300万股，发行价区间为每股4至6美元。按照调整后的发行规模，LYC Healthcare预计募资金额将较此前预期高出67%，对应市值将达到1.37亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260916/32371585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LABU","XLV","XBI","BK4588","IPOS","UDN","MEDX","BK4585","BK4581","STmain","UUP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667670478","title":"新加坡醫療服務提供商LYC Healthcare IPO定價4美元/股 籌資規模上調67%至2500萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667670478","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667670478?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 14:28","pubTimestamp":1789540088,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，在新加坡运营医疗诊所和骨科手术中心的LYC Healthcare于周二提高了即将进行的首次公开募股的拟议发行规模。按照调整后的发行规模，LYC Healthcare预计募资金额将较此前预期高出67%，对应市值将达到1.37亿美元。LYC Healthcare成立于2017年，是一家位于新加坡的多学科专科医疗服务提供商，通过两家运营子公司、5家医疗诊所以及内部先进影像设施，提供一体化的肌肉骨骼医疗服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496725.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","MEDX","IPOS","LABU","STmain","XLV","BK4581","BK4588","XBI","UUP","UDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667670424","title":"新加坡醫療服務提供商LYC Healthcare IPO定價4美元/股 籌資規模上調67%至2500萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667670424","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667670424?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 14:28","pubTimestamp":1789540088,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4581","IPOS","UDN","BK4585","XBI","LABU","MEDX","UUP","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667724676","title":"創新藥概念股表現活躍","url":"https://stock-news.laohu8.com/highlight/detail?id=2667724676","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667724676?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 13:18","pubTimestamp":1789535894,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","MEDX","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667567483","title":"香港：建設國際藥械權威監管機構 建立自主藥械審評能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2667567483","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667567483?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 11:47","pubTimestamp":1789530430,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","MEDX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":3,"totalSize":261,"code":"91000000","status":"200"}]}}